SCM
AEON.WS

Shaolin Capital Management’s AEON Biopharma Inc AEON.WS Stock Holding History

Shaolin Capital Management’s Portfolio AEON.WS Stock Details AEON.WS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-729,332
Closed -$66K – 791
2023
Q2 		$66K Buy
+729,332
New +$54.8K ﹤0.01% 349

Other funds holding AEON.WS

DKCM
Davidson Kempner Capital Management New York $7.33B AUM 56.47% 1-Year Est. Return
LP
LMR Partners London, United Kingdom $45.4B AUM 60.68% 1-Year Est. Return
AC
Athos Capital Hong Kong $324M AUM 16.62% 1-Year Est. Return
WAM
Wolverine Asset Management Chicago, Illinois $10.4B AUM 4.78% 1-Year Est. Return
AC
Aristeia Capital Greenwich, Connecticut $4.82B AUM 24.94% 1-Year Est. Return
TCM
Tenor Capital Management New York $6.49B AUM 3.01% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
QGA
Q Global Advisors Fort Worth, Texas $113M AUM 20.91% 1-Year Est. Return
Hudson Bay Capital Management
Hudson Bay Capital Management Stamford, Connecticut $29B AUM 30.2% 1-Year Est. Return
WA
Whitebox Advisors Minneapolis, Minnesota $8.12B AUM 15.85% 1-Year Est. Return

Shaolin Capital Management's AEON.WS Position: Q1 2024 in Review

Shaolin Capital Management sold out of AEON Biopharma Inc (AEON.WS) in Q1 2024, closing a stake of 917,120 shares — an estimated $91.6K sold.

Shaolin Capital Management first reported a position in AEON.WS in Q3 2021 and held it in 9 quarters. The position peaked at $159K in Q3 2021. 30 funds tracked by Wall St. Rank hold AEON.WS as of Q1 2024.

  • Shaolin Capital Management reported no remaining AEON Biopharma Inc position as of Q1 2024 after selling out during the quarter.
  • Shaolin Capital Management sold 917,120 AEON Biopharma Inc shares in Q1 2024, an estimated $91.6K.
  • Shaolin Capital Management first reported a position in AEON Biopharma Inc in Q3 2021 and held it in 9 quarters.
  • Shaolin Capital Management's AEON Biopharma Inc position peaked at $159K in Q3 2021.
  • 30 funds tracked by Wall St. Rank held AEON Biopharma Inc as of Q1 2024.

Based on Shaolin Capital Management's 13F filing for Q1 2024, filed 15 May 2024.